Federal Register Notice: FDA is reopening until 5/2 the comment period for a 2/7 Federal Register notice announcing a meeting of the Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee. FDA had requested comments on the 3/8-9 meeting of the panel to discuss and make recommendations on scientific issues on DTC genetic tests that make medical claims. To view this notice, click here.
